From January 1, 2024 to March 31, 2024, the company has repurchased 12,971,308 shares, representing 2.43% for CNY 147.82 million. With this, the company has completed the repurchase of 20,172,808 shares, representing 3.79% for CNY 243.66 million under the buyback announced on November 20, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.51 CNY | -5.02% | -9.18% | -36.63% |
May. 10 | ChenGuang Biotech Group Co., Ltd. Approves Cash Dividend for the Year 2023 | CI |
Apr. 24 | ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.63% | 602M | |
+0.15% | 282B | |
-7.01% | 90.34B | |
-5.08% | 42.62B | |
+1.47% | 41.49B | |
+5.35% | 39.72B | |
+4.01% | 38.25B | |
-14.17% | 30.65B | |
-8.78% | 27.31B | |
+8.66% | 24.42B |
- Stock Market
- Equities
- 300138 Stock
- News ChenGuang Biotech Group Co., Ltd.
- Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023.